SCHEMBL14027014

SCHEMBL14027014

O=Cc1ccc(N2CCC3(CC2)CCN(C2CCC2)CC3)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.56
TRIM33 Q9UPN9 1/20 0.56
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HRH3 Q9Y5N1 5/20 0.49
L3MBTL3 Q96JM7 4/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
FFAR4 Q5NUL3 1/20 0.41
MBTD1 Q05BQ5 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TP53BP1 Q12888 1/20 0.40
L3MBTL4 Q8NA19 1/20 0.40
CYP2C9 P11712 1/20 0.39
MMP2 P08253 1/20 0.39
MMP13 P45452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4136516 0.86 HRH3 (0.47) HRH3L3MBTL3L3MBTL1FFAR4MBTD1
SCHEMBL12274140 0.84 TRIM24 (0.61) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4141352 0.82 FFAR4 (0.48) ALDH1A1HRH3L3MBTL3L3MBTL1FFAR4
SCHEMBL4125512 0.82 L3MBTL3 (0.50) HRH3L3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL4117914 0.81 L3MBTL3 (0.73) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4938363 0.80 L3MBTL3 (0.71) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4123114 0.80 HRH3 (0.56) ALDH1A1KDM4EHRH3L3MBTL3L3MBTL1
SCHEMBL4136511 0.79 KMT2A (0.62) ALDH1A1HRH3L3MBTL3L3MBTL1MBTD1
SCHEMBL4131556 0.79 HRH3 (0.60) HRH3L3MBTL3L3MBTL1FFAR4MBTD1
SCHEMBL4139050 0.79 HRH3 (0.52) HRH3L3MBTL3L3MBTL1CYP2C9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080247964-A1 SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION 2008-10-09 US disclosed
US-20080247964-A1 SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION 2008-10-09 US disclosed
WO-2007133561-A2 SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION (US) 2007-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080247964-A1 SUBSTITUTED AZASPIRO DERIVATIVES HRH3, HRH4, HRH1 TRIM24 4073/4885TRIM33 1875/4885ALDH1A1 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.